兰卫医学
(301060)
| 流通市值：33.90亿 | | | 总市值：38.21亿 |
| 流通股本：3.55亿 | | | 总股本：4.01亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 744,823,091.7 | 828,951,466.14 | 684,824,917.78 | 723,526,195.64 |
| 应收票据及应收账款 | 758,465,233.35 | 789,299,499.6 | 956,121,172.3 | 1,002,133,132.82 |
| 其中：应收票据 | 1,271,977.69 | 2,584,099.64 | 2,647,029.34 | 1,422,073.78 |
| 应收账款 | 757,193,255.66 | 786,715,399.96 | 953,474,142.96 | 1,000,711,059.04 |
| 应收款项融资 | 13,955,963.38 | 18,931,236.37 | 13,750,918.48 | 20,833,473.93 |
| 预付款项 | 10,423,796.74 | 4,757,068.96 | 12,335,027.24 | 10,177,429.23 |
| 其他应收款合计 | 14,304,164.31 | 14,537,235.68 | 12,629,899.76 | 11,901,465.78 |
| 存货 | 369,701,449.12 | 306,089,217.82 | 304,498,589.15 | 352,724,478.14 |
| 合同资产 | 462,646 | 397,666 | - | - |
| 其他流动资产 | 40,229,490.92 | 35,677,207.52 | 34,342,121.23 | 39,669,015.36 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,007,317,551.25 | 1,998,640,598.09 | 2,018,502,645.94 | 2,160,965,190.9 |
| 非流动资产: | | | | |
| 长期股权投资 | 1,689,271.35 | 1,759,448.9 | 1,866,761.26 | 15,185,084.29 |
| 固定资产 | 441,222,630.87 | 451,114,120.38 | 454,443,041.7 | 462,542,757.29 |
| 在建工程 | 2,421,373.47 | 991,843.26 | 8,292,804.59 | 3,677,486.75 |
| 使用权资产 | 27,047,883.13 | 30,477,841.97 | 35,467,753.09 | 34,052,477.49 |
| 无形资产 | 23,267,836.46 | 24,453,883.34 | 23,420,197.26 | 24,407,811.38 |
| 商誉 | 7,664,887.29 | 7,664,887.29 | 7,664,887.29 | 7,664,887.29 |
| 长期待摊费用 | 26,579,967.89 | 30,040,684.88 | 36,801,218.6 | 44,108,217.05 |
| 递延所得税资产 | 75,265,516.23 | 73,823,620.88 | 73,958,276.6 | 57,082,517.4 |
| 其他非流动资产 | 3,772,697.97 | 4,367,497.71 | 8,420,650.32 | 6,942,135.82 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 608,932,064.66 | 624,693,828.61 | 650,335,590.71 | 655,663,374.76 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,616,249,615.91 | 2,623,334,426.7 | 2,668,838,236.65 | 2,816,628,565.66 |
| 流动负债: | | | | |
| 短期借款 | 95,070,833.33 | 95,106,330.14 | 130,409,709.22 | 160,429,491.07 |
| 应付票据及应付账款 | 434,488,278.85 | 388,993,543.18 | 374,040,651.57 | 414,560,466.1 |
| 应付账款 | 434,488,278.85 | 388,993,543.18 | 374,040,651.57 | 414,560,466.1 |
| 合同负债 | 14,425,463.89 | 15,116,271.56 | 7,356,976.03 | 8,684,774.47 |
| 应付职工薪酬 | 25,762,971.5 | 37,799,678.56 | 21,796,401.38 | 24,054,516.93 |
| 应交税费 | 17,229,673.92 | 24,212,317.07 | 11,313,124.73 | 8,606,494.43 |
| 其他应付款合计 | 13,776,866.09 | 25,324,861.74 | 11,276,094.94 | 17,081,508.44 |
| 应付股利 | - | - | - | 3,675,000 |
| 一年内到期的非流动负债 | 27,824,439.6 | 27,217,490.25 | 27,756,278.25 | 26,397,803.35 |
| 其他流动负债 | 1,739,088.51 | 1,818,902.71 | 585,721.95 | 828,192.02 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 630,317,615.69 | 615,589,395.21 | 584,534,958.07 | 660,643,246.81 |
| 非流动负债: | | | | |
| 长期借款 | 125,700,000 | 133,700,000 | 133,700,000 | 141,200,000 |
| 租赁负债 | 13,841,201.02 | 18,267,149.57 | 23,042,586.78 | 22,679,050.31 |
| 预计负债 | 25,020,662.23 | 25,020,662.23 | 5,088,191.84 | 5,088,191.84 |
| 递延收益 | 9,459,890.78 | 10,420,720.53 | 9,999,584.75 | 10,640,656.78 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 174,021,754.03 | 187,408,532.33 | 171,830,363.37 | 179,607,898.93 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 804,339,369.72 | 802,997,927.54 | 756,365,321.44 | 840,251,145.74 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 400,517,000 | 400,517,000 | 400,517,000 | 400,517,000 |
| 资本公积 | 553,960,780.01 | 553,960,780.01 | 553,960,780.01 | 553,960,780.01 |
| 减:库存股 | 23,006,777.49 | 23,006,777.49 | 19,401,342.98 | 19,401,342.98 |
| 其他综合收益 | -653,308.3 | -653,308.3 | -653,308.3 | -653,308.3 |
| 盈余公积 | 86,525,659.79 | 86,525,659.79 | 86,525,659.79 | 86,525,659.79 |
| 未分配利润 | 632,704,207.49 | 640,785,068.28 | 709,637,522.77 | 765,818,843.42 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,650,047,561.5 | 1,658,128,422.29 | 1,730,586,311.29 | 1,786,767,631.94 |
| 少数股东权益 | 161,862,684.69 | 162,208,076.87 | 181,886,603.92 | 189,609,787.98 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,811,910,246.19 | 1,820,336,499.16 | 1,912,472,915.21 | 1,976,377,419.92 |
| 负债和股东权益合计 | 2,616,249,615.91 | 2,623,334,426.7 | 2,668,838,236.65 | 2,816,628,565.66 |
| 公告日期 | 2025-04-28 | 2025-04-28 | 2024-10-30 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |